PerkinElmer's LAS Head to Replace Summe as CEO in February; Q2 Revenue, Profits Rise

Jul 27, 2007

NEW YORK (GenomeWeb News) — PerkinElmer today said Rob Friel, president of the company’s Life and Analytical Sciences business, will succeed Gregory Summe as CEO in February.

Initially, Friel will become president and chief operating officer of PerkinElmer on Aug. 1, and the firm expects him to be elected CEO six months later. At that time, Summe will become executive chairman of the board, a title he will retain through the annual shareholders meeting in April 2009, PerkinElmer said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Like Sears, But With Cells

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Infertile Mouse No More

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

PGD Growth Spurt

China is embracing preimplantation genetic diagnosis, Nature News reports.

This Week in PLOS

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

Main menu